Boxed warning
Caution: Do not use if imprinted seal under cap is broken or missing
Caution: Do not use if imprinted seal under cap is broken or missing
Other Information Store at 15° - 30°C (59° – 86° F).
Caution: Do not use if imprinted seal under cap is broken or missing
Drug facts
Active Ingredient (in each tablet)
Acetaminophen USP....... 500 mg
Caffeine USP....................60 mg
Pyrilamine Maleate USP......15 mg
Purpose
Pain reliever/Diuretic/Antihistamine
Use(s)
for the temporary relief of these symptoms associated with menstrual periods:
Warnings:
Liver warning:
This product contains acetaminophen. Severe liver damage may occur if you take:
Allergy Alert:
Acetaminophen may cause severe skin or severe allergy reactions. Symptoms may include:
If a skin or general allergic reaction occurs, stop use and seek medical help right away
Do not use:
Ask a doctor before use if you have:
Ask a doctor or pharmacist before use if you are
When using this product
Stop use and ask a doctor if:
If pregnant or breast feeding, ask a health care professional before use.
Overdose warning
In case of overdose, get medical help or contact a poison control center 1-800-222-1222 right away. Quick medical help attention is critical for adults as well as children even if you do not notice any signs or symptoms.
Keep out of reach of children.
Directions
Other Information
Inactive Ingredients
pregelatinized starch, microcrystalline cellulose, croscarmellose sodium, povidone, colloidal silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol, titanium dioxide, talc
Questions or comments?
1-855-642-2594
Manufactured for:
Apnar Pharma LP
CHINO, CA, 91710
Rev.: 05/2022
†This product is not manufactured or distributed by Bayer Healthcare, LLC owner of the registered trademark Midol Complete®
APNAR PHARMA LP
NDC: 24689-121-01
Acetaminophen 500mg, Caffeine 60mg, Pyrilamine Maleate 15mg Tablets -20's Tablets
APNAR PHARMA LP
NDC: 24689-121-02
Acetaminophen 500mg, Caffeine 60mg, Pyrilamine Maleate 15mg Tablets -500's Tablets
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24689-121-01 | 2025-02-01 | C162847 | 48780-1 | 2cef2736-6dbb-d83d-e063-dadaa90ab31f | Acetaminophen 500mg, Caffeine 60mg, Pyrilamine Maleate 15mg Tablets |
| 24689-121-02 | 2025-02-01 | C162847 | 48780-1 | 2cef2736-6dbb-d83d-e063-dadaa90ab31f | Acetaminophen 500mg, Caffeine 60mg, Pyrilamine Maleate 15mg Tablets |
| 24689-121-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-6dbb-d83d-e063-dadaa90ab31f | Acetaminophen 500mg, Caffeine 60mg, Pyrilamine Maleate 15mg Tablets |
| 24689-121-02 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-6dbb-d83d-e063-dadaa90ab31f | Acetaminophen 500mg, Caffeine 60mg, Pyrilamine Maleate 15mg Tablets |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24689-121 | 24689-121-01, 24689-121-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POVIDONE K30 | U725QWY32X | IACT |
| CAFFEINE | 3G6A5W338E | ACTIB |
| WATER | 059QF0KO0R | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| TALC | 7SEV7J4R1U | IACT |
| PYRILAMINE MALEATE | R35D29L3ZA | ACTIB |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 45d32473-7a94-266d-e063-6394a90a4810 | e2308622-0b91-3cb4-e053-2a95a90a6149 | 2025-12-13 | Boxed warning, Warnings | e2308622-0b91-3cb4-e053-2a95a90a6149 |
Adverse event summaries are temporarily unavailable. Other product information remains available.